All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

278

Reset

278 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • ICP-488Phase 33 trials

    Beijing InnoCare Pharma Tech Co., Ltd. · Plaque Psoriasis Patients, Primary Sjögren's Syndrome, Cutaneous Lupus Erythematosus (CLE)

  • LNK01001Phase 33 trials

    Lynk Pharmaceuticals Co., Ltd · Ankylosing Spondylitis, Atopic Dermatitis, Rheumatoid Arthritis

  • PP405 0.05%PP405Phase 33 trials

    Pelage Pharmaceuticals, Inc. · Androgenetic Alopecia

  • QY201Phase 33 trials

    E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. · Adult Subjects With Non-Segmental Vitiligo, Atopic Dermatitis (AD), Adolescent Participants With Moderate to Severe Atopic Dermatitis (AD)

  • Beijing VDJBio Co., LTD. · Anti IL-6R, Idiopathic Multicentric Castleman's Disease, Castleman's Disease, Multicentric

  • RocatinlimabAMG 451Phase 33 trials

    Amgen · Atopic Dermatitis

  • SG301Phase 33 trials

    Hangzhou Sumgen Biotech Co., Ltd. · Systemic Lupus Erythematosus (SLE), Relapsed/Refractory Multiple Myeloma, Antibody Mediated Rejection

  • SHR-1314Phase 33 trials

    Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Active Non-radiographic Axial Spondyloarthritis, Children and Adolescents Aged 6 to 18 With Moderate-to-Severe Plaque Psoriasis, Psoriatic Arthritis

  • TQH2722Phase 33 trials

    Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. · Seasonal Allergic Rhinitis, Atopic Dermatitis

  • Zola-celBMS-986353, CC-97540Phase 33 trials

    Bristol Myers Squibb · Systemic Sclerosis, Lupus Erythematosus, Systemic, Lupus Nephritis

  • ABBV-722Phase 32 trials

    AbbVie · Rheumatoid Arthritis, Systemic Sclerosis

  • ADSTEM Inj.Phase 32 trials

    EHL Bio Co., Ltd. · Atopic Dermatitis

  • AfimetoranBMS-986256, BLN-256Phase 32 trials

    Beeline Medicines Corporation · Systemic Lupus Erythematosus, Cutaneous Lupus Erythematosus (CLE), Systematic Lupus Erythematosus

  • AK111Phase 32 trials

    Akeso · Psoriasis, Skin Diseases, Ankylosing Spondylitis

  • BDB-001Phase 32 trials

    Staidson (Beijing) Biopharmaceuticals Co., Ltd · ANCA Associated Vasculitis (AAV), ANCA-associated Vasculitis

  • BFB759Phase 32 trials

    Bluefin Biomedicine, Inc. · Atopic Dermatitis (AD), Hidradenitis Suppurativa (HS)

  • CMS-D001Phase 32 trials

    Dermavon Holdings Limited · Moderate to Severe Plaque Psoriasis, Moderate to Severe Atopic Dermatitis

  • DZPCDP7657, Dapirolizumab pegolPhase 32 trials

    UCB · Systemic Lupus Erythematosus

  • HS-20137QX004NPhase 32 trials

    Hansoh BioMedical R&D Company · Moderate-to-severe Plaque Psoriasis

  • IBI112Phase 32 trials

    Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. · Psoriasis

  • MH004Phase 32 trials

    Minghui Pharmaceutical (Hangzhou) Ltd · Vitiligo, Atopic Dermatitis (AD)

  • NetakimabPhase 32 trials

    Biocad · Plaque Psoriasis

  • PicankibartPhase 32 trials

    Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. · Psoriatic Arthritis, Plaque Psoriasis

  • piclidenosonPhase 32 trials

    Can-Fite BioPharma · Plaque Psoriasis, Lowe Syndrome

  • SHR0302Phase 32 trials

    Jiangsu HengRui Medicine Co., Ltd. · Non-segmental Vitiligo, Psoriatic Arthritis

  • SoquelitinibCPI-818Phase 32 trials

    Corvus Pharmaceuticals, Inc. · Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema

  • StapokibatrtPhase 32 trials

    Keymed Biosciences Co.Ltd · Atopic Dermatitis

  • SYHX1901Phase 32 trials

    CSPC Ouyi Pharmaceutical Co., Ltd. · Moderate to Severe Plaque Psoriasis, Severe Alopecia Areata

  • TEV-53408Phase 32 trials

    Teva · Vitiligo, Celiac Disease

  • TILDPhase 32 trials

    Sun Pharmaceutical Industries Limited · Active Psoriatic Arthritis

  • VC005 groupPhase 32 trials

    Jiangsu vcare pharmaceutical technology co., LTD · Atopic Dermatitis, Moderate to Severe Atopic Dermatitis

  • WD-890Phase 32 trials

    Zhejiang Wenda Pharma Technology LTD. · Brief Description of Focus of Study, Moderate to Severe Plaque Psoriasis

  • Alumis Inc · Plaque Psoriasis, Psoriasis (PsO), Psoriasis

  • CMAB015Phase 31 trial

    Taizhou Mabtech Pharmaceutical Co.,Ltd · Psoriasis

  • CTP-543Phase 31 trial

    Sun Pharmaceutical Industries, Inc. · Alopecia Areata

  • DA-001Phase 31 trial

    Applied Biology, Inc. · Telogen Effluvium, Female Pattern Hair Loss, Female Pattern Hair Loss, Androgenic Alopecia

  • DA-007Phase 31 trial

    Applied Biology, Inc. · Chemotherapy Induced Alopecia, Chemotherapy Side Effects

  • GNR-068Phase 31 trial

    AO GENERIUM · Plaque Psoriasis

  • GS101Phase 31 trial

    Jiangsu Genscend Biopharmaceutical Co., Ltd · Atopic Dermatitis (AD)

  • HPP737Phase 31 trial

    Newsoara Biopharma Co., Ltd. · Psoriasis

  • IBI3027Phase 31 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Atopic Dermatitis

  • LevilimabPhase 31 trial

    Biocad · Rheumatoid Arthritis

  • LW402Phase 31 trial

    Shanghai Longwood Biopharmaceuticals Co., Ltd. · Moderate to Severe Atopic Dermatitis

  • LZM012Phase 31 trial

    Livzon Pharmaceutical Group Inc. · Psoriasis

  • N1087Phase 31 trial

    Eurofarma Laboratorios S.A. · Female Pattern Hair Loss, Female Pattern Hair Loss, Androgenic Alopecia

  • Alumis Inc · Plaque Psoriasis, Psoriasis (PsO), Psoriasis

  • PG-011GelPG-011Gel 3%Phase 31 trial

    Prime Gene Therapeutics Co., Ltd. · Atopic Dermatitis

  • mAbxience Research S.L. · Rheumatoid Arthritis (RA)

  • QL2106Phase 31 trial

    Qilu Pharmaceutical Co., Ltd. · Plaque Psoriasis

  • QL2108Phase 31 trial

    Qilu Pharmaceutical Co., Ltd. · Atopic Dermatitis

NewerPage 2 of 6Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.